Entero Healthcare Solutions Limited (IN:ENTERO)
:ENTERO
Want to see IN:ENTERO full AI Analyst Report?
ENTERO Stock Chart & Stats
₹1154.55
-₹7.15(-0.49%)
At close: 4:00 PM EST
₹1154.55
-₹7.15(-0.49%)
Day’s Range― - ―
52-Week Range₹944.00 - ₹1,509.90
Previous CloseN/A
Volume53.16K
Average Volume (3M)6.57K
Market Cap
₹51.84B
Enterprise Value₹55.51B
Total Cash (Recent Filing)₹3.49B
Total Debt (Recent Filing)₹4.43B
Price to Earnings (P/E)40.4
Beta0.69
Next Earnings
Jun 03, 2026EPS Estimate
9.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.90
Shares Outstanding43,510,937
10 Day Avg. Volume6,792
30 Day Avg. Volume6,572
Financial Highlights & Ratios
PEG Ratio0.52
Price to Book (P/B)2.91
Price to Sales (P/S)0.99
P/FCF Ratio-54.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,350.00Price Target Upside16.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)44.48
Revenue Forecast (FY)₹81.39B
Bulls Say, Bears Say
Bulls Say
Revenue Scale And Profitability TurnaroundSustained multi-year revenue scaling and a return to positive net income indicate the distribution model is achieving meaningful commercial traction. Over 2–6 months this supports stronger bargaining power with suppliers, greater fixed-cost absorption and a clearer path to durable operating leverage as volumes normalize.
Improved Balance-sheet With Low LeverageLower leverage and a materially larger equity base increase financial resilience and reduce refinancing risk. This structural improvement gives management flexibility to invest in logistics, technology, or working-capital buffers without immediate dependency on high-cost external funding, improving durability.
Essential, Services-led Distribution ModelCore business provides essential pharma distribution and supply-chain services to pharmacies and hospitals. Recurring distribution volumes and fee-bearing logistics/managed services create durable revenue streams and sticky customer relationships that are less cyclical and support long-term market position.
Bears Say
Persistent Negative Operating And Free Cash FlowEarnings have not converted to cash, with consistent negative operating and free cash flow. Over months this raises funding and liquidity risk, constrains capex or working-capital investment, and forces reliance on external financing which can pressure strategy and margins if sustained.
Thin, Volatile Gross Margins And 2025 CompressionMaterial gross-margin compression and historically thin margins increase sensitivity to supplier pricing, competitive discounting and cost inflation. Structurally, this limits the firm's ability to build robust operating margins and weakens the buffer against industry shocks over the medium term.
Modest Returns On Equity Despite Equity GrowthAlthough equity has grown, ROE remains modest, suggesting capital is not yet deployed with high efficiency. Over time this can limit shareholder returns and require sustained high revenue growth to justify the larger capital base, challenging long-term capital allocation.
Entero Healthcare Solutions Limited News
ENTERO FAQ
What was Entero Healthcare Solutions Limited’s price range in the past 12 months?
Entero Healthcare Solutions Limited lowest stock price was ₹944.00 and its highest was ₹1509.90 in the past 12 months.
What is Entero Healthcare Solutions Limited’s market cap?
Entero Healthcare Solutions Limited’s market cap is ₹51.84B.
When is Entero Healthcare Solutions Limited’s upcoming earnings report date?
Entero Healthcare Solutions Limited’s upcoming earnings report date is Jun 03, 2026 which is in 33 days.
How were Entero Healthcare Solutions Limited’s earnings last quarter?
Entero Healthcare Solutions Limited released its earnings results on Feb 12, 2026. The company reported ₹7.9 earnings per share for the quarter, missing the consensus estimate of ₹8.8 by -₹0.9.
Is Entero Healthcare Solutions Limited overvalued?
According to Wall Street analysts Entero Healthcare Solutions Limited’s price is currently Undervalued.
Does Entero Healthcare Solutions Limited pay dividends?
Entero Healthcare Solutions Limited does not currently pay dividends.
What is Entero Healthcare Solutions Limited’s EPS estimate?
Entero Healthcare Solutions Limited’s EPS estimate is 9.1.
How many shares outstanding does Entero Healthcare Solutions Limited have?
Entero Healthcare Solutions Limited has 43,510,937 shares outstanding.
What happened to Entero Healthcare Solutions Limited’s price movement after its last earnings report?
Entero Healthcare Solutions Limited reported an EPS of ₹7.9 in its last earnings report, missing expectations of ₹8.8. Following the earnings report the stock price went up 0.195%.
Which hedge fund is a major shareholder of Entero Healthcare Solutions Limited?
Currently, no hedge funds are holding shares in IN:ENTERO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, nursing homes, and healthcare clinics in India. It is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. The company was incorporated in 2018 and is based in Mumbai, India.
ENTERO Stock 12 Month Forecast
Average Price Target
₹1,350.00
▲(16.93% Upside)
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Medi Assist Healthcare Services Limited
―
Panacea Biotec Limited
―
Thyrocare Technologies Ltd
―
Yatharth Hospital and Trauma Care Services Limited
―